Karin Vroom

Karin Vroom is a Principal Scientist at Merck with a diverse background in molecular biology and engineering design. They have contributed to significant advancements in antibiotic production and antibody discovery, managing a team focused on high-throughput sequencing and characterization of therapeutic candidates. Karin's previous roles include positions at Stanford University and Abcam, where they developed innovative techniques in protein-based biomaterials and antibody isolation. They hold a B.S. in Chemical Engineering from the University of Dayton and both an M.S. and Ph.D. in Chemical Engineering from Stanford University.